Legal Opinion
In re Epipen
District Court, D. Kansas
Decided August 20, 2018No. MDL No: 2785; Case No. 17-md-2785-DDC-TJJPublishedCited by 25 opinions
1Opinion of the Court
Daniel D. Crabtree, United States District Judge
This Order addresses the pending Motions to Dismiss in one of the two separate tracks of this MDL-the consumer class cases track. The consumer class track consists of cases filed by individual consumers or third-party payors who allege they purchased EpiPens for consumption by themselves, their families, or their members, employees, insureds, participants, or beneficiaries. After the Judicial Panel on Multidistrict Litigation *1276transferred five consumer class cases and one other filed by Sanofi-Aventis U.S. LLC ("Sanofi") to our court for…
2Cases cited176 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
- Spokeo, Inc. v. RobinsSupreme Court of the United States · 2016
- Allen v. WrightSupreme Court of the United States · 1984
171 more not listed; retrieve them via the Exa API.
3Cited by25 opinions
- City of Rockford v. Mallinckrodt ARD, Inc.District Court, E.D. Illinois · 2019
- MSP Recovery Claims, Series LLC v. Lundbeck LLCCourt of Appeals for the Fourth Circuit · 2025
- Mayor and City Council v. Actelion Pharmaceuticals Ltd.Court of Appeals for the Fourth Circuit · 2021
- In re Effexor Antitrust Litig.District Court, D. New Jersey · 2018
- In re Effexor Antitrust Litig.District Court, D. New Jersey · 2018
20 more not listed; retrieve them via the Exa API.